Novelion Therapeutics appoints Murray Stewart, M.D., as executive VP & head of R&D
Novelion Therapeutics announced the appointment of Murray Stewart, M.D. as Executive VP, Head of R&D. Dr. Stewart joins Novelion from GlaxoSmithKline where he was CMO with global responsibility for patient well-being across the vaccines, pharmaceutical and consumer business units. October 12, 2017